Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).
Tang C, Mistry H, Bayman N, Chan C, Cobben D, Faivre-Finn C, Harris M, Kennedy J, Pemberton L, Price G, Sheikh H, Woolf D, Coote J, Salem A. Tang C, et al. Radiother Oncol. 2021 Jul;160:78-81. doi: 10.1016/j.radonc.2021.04.014. Epub 2021 Apr 24. Radiother Oncol. 2021. PMID: 33901563
Modern management of small-cell lung cancer.
Ferraldeschi R, Baka S, Jyoti B, Faivre-Finn C, Thatcher N, Lorigan P. Ferraldeschi R, et al. Drugs. 2007;67(15):2135-52. doi: 10.2165/00003495-200767150-00003. Drugs. 2007. PMID: 17927281 Review.
Radiotherapy for lung cancer in the elderly.
Bayman N, Alam N, Faivre-Finn C. Bayman N, et al. Lung Cancer. 2010 May;68(2):129-36. doi: 10.1016/j.lungcan.2009.12.004. Epub 2010 Jan 15. Lung Cancer. 2010. PMID: 20079949 Review.
Lung cancer after treatment for breast cancer.
Lorigan P, Califano R, Faivre-Finn C, Howell A, Thatcher N. Lorigan P, et al. Lancet Oncol. 2010 Dec;11(12):1184-92. doi: 10.1016/S1470-2045(10)70056-5. Epub 2010 Jun 10. Lancet Oncol. 2010. PMID: 20541465 Review.
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
Califano R, Griffiths R, Lorigan P, Ashcroft L, Taylor P, Burt P, Lee L, Chittalia A, Harris M, Faivre-Finn C, Thatcher N, Blackhall F. Califano R, et al. Lung Cancer. 2011 Sep;73(3):338-44. doi: 10.1016/j.lungcan.2011.01.001. Epub 2011 Feb 5. Lung Cancer. 2011. PMID: 21296449 Clinical Trial.
322 results